Zongertinib to Target HER2-Driven Resistance in EGFR Mutation-Positive NSCLC: A Case Report. (PubMed, Clin Lung Cancer) - Sep 18, 2026 - No abstract available
Journal • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • EGFR
|
|
Ana López-Martín; Cristina Serrano-Gómez; Helena Bote de Cabo; Javier Baena-Espinar; Javier Torres-Jiménez; Jon Zugazagoitia; Luis Paz-Ares; María Zurera-Berjaga; Santiago Ponce-Aix
|